The Laerdal Million Lives Fund is committed to investing in entrepreneurs who are developing and deploying emerging technologies capable of saving lives across the globe. Our investment thesis aims to contribute to Laerdal’s impact goal of helping save 1 million lives annually by 2030. To achieve this, we prioritize investments that can be globally scalable and meaningful impact mortality rates by improving healthcare access, quality and outcomes to all populations regardless of demographics or geography.
We target investments in commercial-stage companies that address mortality rates across clinical areas, such as maternal, neonatal, emergency medicine, critical care and surgery, and provide better medical education and training to providers and patients. By supporting the companies that are developing innovative and enabling technologies, we hope to play a significant role in reducing mortality across these sectors, which account for over 20 million deaths annually today.
The Laerdal Million Lives Fund is supported by and affiliated with the Laerdal family. Collectively, we are working toward a future where no one dies or is disabled unnecessarily during birth or from sudden illness, trauma, or medical errors.
has remained a global market leader within resuscitation and patient care since modern lifesaving methods were established in 1960. The company employs 1,600 people in 25 countries.
was established in 1980 to provide financial support to practically oriented research projects. To date, the foundation has funded nearly 2,000 projects with over $40 million.
Laerdal Global Health
is a non-profit organization established in 2010 and dedicated to helping save lives of mothers and newborns in low-resource settings.
Laerdal Million Lives Fund
is a $100 million venture fund created in 2019 to pursue direct investments in enabling technologies and companies that can accelerate Laerdal‘s global impact goal of saving over one million lives annually by 2030.